IL-18 also enhances anti-PD1 antitumor effect in murine colon cancer (CT26) or melanoma (B16F10) peritoneal dissemination models in a NK and CD8+ T cell-dependent manner. This evidence concerns the gene IL18 and colonic neoplasm.